rubidium has been researched along with 2,2,5,7,8-pentamethyl-1-hydroxychroman in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dunlop, J; Jow, F; Kowal, D; Maddox, T; Mekonnen, B; Shen, R; Tseng, E; Wang, K | 1 |
1 other study(ies) available for rubidium and 2,2,5,7,8-pentamethyl-1-hydroxychroman
Article | Year |
---|---|
Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Topics: Animals; Anthracenes; Benzodiazepines; CHO Cells; Chromans; Cricetinae; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gene Expression; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; KCNQ1 Potassium Channel; Long QT Syndrome; Membrane Potentials; Myocardium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Potassium Chloride; Rats; Reproducibility of Results; Risk Factors; Rubidium; Spectrophotometry, Atomic; Tetraethylammonium | 2006 |